PharmAthene (PIP) Reports Data from rPA Anthrax Vaccine Programs and Valortim(R) at Bacillus - ACT Conference
Tweet Send to a Friend
PharmAthene, Inc. (Amex: PIP) announced today that data from the Company's third generation recombinant protective antigen anthrax vaccine program and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
